Clinical trial
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
NCT00058123 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00058123 |
|---|---|
| Title | Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma |
| Official title | A Phase II Trial of Poly ICLC in Patients With Recurrent Anaplastic Glioma |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | poly ICLC |
| Enrollment | 55 |
| Start date | Mar 7, 2003 |
| Primary completion | Oct 6, 2007 |
| Completion | Jan 2, 2009 |
| First posted | Apr 9, 2003 |
| Last update posted | Aug 21, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: